|
Report Date : |
09.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
EMA PHARM |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Year of Establishment : |
1995 |
|
|
|
|
Legal Form : |
Limited Liability Partnership |
|
|
|
|
Line of Business : |
Production and marketing
of herbal pharmaceutical preparations |
|
|
|
|
No. of Employees : |
110 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : EMA PHARM
Country of Origin : Egypt
Legal Form : Limited Liability Partnership
Registration Date : 1995
Issued Capital : £E 500,000
Paid up Capital : £E 500,000
Total Workforce : 110
Activities : Production and marketing of herbal pharmaceutical preparations.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
EMA PHARM
Registered &
Physical Address
Building : Pharma Plaza Building
Street : Asma Fahmy Street
Area : Nozha, Nasr City
Town : Cairo
Country : Egypt
Telephone : (20-2) 24177383
/ 24177407
Facsimile : (20-2) 24177383
Email : info@emapharm.com / emapharm@hotmail.com
Premises
Subject operates
from a medium sized suite of offices that are rented and located in the
Suburban Business Area of Cairo.
Branch Office
(s)
Location Description
·
Alexandria Sales
Office
Tel: (20-12) 2464968
·
Mansoura Sales Office
Tel: (20-12) 2467708
·
Sohag Sales Office
Tel: (20-93) 313494
Name Position
·
Ahmed Badr Managing
Partner
·
Emam El Amin Partner
·
Alaa Abd El Moaaty Finance
Manager
·
Dr Khaled El Zekhary Sales Manager
Date of Establishment : 1995
Legal Form :
Limited Liability
Partnership
Issued Capital : £E 500,000
Paid up Capital : £E 500,000
Name of
Shareholder (s)
·
Ahmed Badr
·
Emam El Amin
Activities: Engaged in the production and marketing of herbal pharmaceutical preparations.
Subject’s products are manufactured at 3rd party facilities
including Pharoania Pharmaceuticals, Amriya pharmaceuticals, Technopharm Egypt,
and R. P Sherer Egypt.
Import Countries: Canada, United States of America, China and
India
International
Suppliers:
·
Accucaps Canada
·
Sante Naturelle Canada
·
Thera Plantes Canada
·
Flora Canada
·
Jingsu Soho International Group
Corporation China
·
Shaanxi Scidoor Hi-Tech Biology Co Ltd China
·
Hetero Chemicals Ltd India
Brand Names: EMA PHARM
Operating Trend: Steady
Subject has a
workforce of approximately 110 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/10: Year
Ending 31/12/11:
Total Sales £E 31,650,000 £E 34,720,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
Egyptian
American Bank
4 & 6 Hassan Sabri
Zamalek
PO Box: 1825
Cairo
Tel: (20-2) 33416150
Fax: (20-2) 33420265
·
National
Bank of Egypt
24, Sherif Street
Cairo
Tel: (20-2) 33924175
Fax: (20-2) 33924143
No complaints
regarding subject’s payments have been reported.
Local sources
report that payment obligations are met in a generally timely manner and the
operating history is clear. As such the company is deemed a fair trade risk and
the above credit figure is considered to be within subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.34 |
|
UK Pound |
1 |
Rs.86.09 |
|
Euro |
1 |
Rs.69.37 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.